Reversing oral anticoagulants with a focus on Andexanet Alfa
1:00:57
Update on Andexanet Alfa for Reversal of FXa Inhibitors: Annexa-I Trial Webinar
20:59
Anticoagulant Reversal
56:16
VTE and Movement
58:43
DOACs in extremes of body weight
12:09
Oral Anticoagulants || Warfarin || Rivaroxaban || Apixiban || Dabigatran
1:04:13
Oct. 2024 PEP Talk: Anticoagulation and Reversal Agents
43:22
The PERIOD Study
27:51